A study of a different dose-intense infusion schedule of phenylacetate in patients with recurrent primary brain tumors: a North American brain tumor consortium report Article

Chang, SM, Kuhn, JG, Robins, HI et al. (2003). A study of a different dose-intense infusion schedule of phenylacetate in patients with recurrent primary brain tumors: a North American brain tumor consortium report . INVESTIGATIONAL NEW DRUGS, 21(4), 429-433. 10.1023/A:1026299118067

cited authors

  • Chang, SM; Kuhn, JG; Robins, HI; Schold, SC; Spence, AM; Berger, MS; Mehta, MP; Pollack, I; Gilbert, M; Prados, MD

sustainable development goals

authors

publication date

  • November 1, 2003

webpage

published in

keywords

  • CELLS
  • HYPERAMMONEMIA
  • Life Sciences & Biomedicine
  • MALIGNANT GLIOMA
  • Oncology
  • Pharmacology & Pharmacy
  • Science & Technology
  • dose schedules
  • pharmacokinetics
  • phenylacetate
  • recurrent brain tumor

Digital Object Identifier (DOI)

publisher

  • KLUWER ACADEMIC PUBL

start page

  • 429

end page

  • 433

volume

  • 21

issue

  • 4